Friday, September 29, 2023

561.316.3330

Biotechnology News Magazine

IAI Announces Medical Assist ELECYLINDER Series

Latest Posts

Airway Therapeutics Completes Dose Escalation in Phase 1b Trial of Zelpultide Alfa (AT-100) for Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

Airway Therapeutics began recruiting patients on March 28, 2023, for daily treatment up to 7 days at the highest dose of zelpultide alfa (rhSP-D) following a Data Safety Monitoring Committee (DSMC) report of no safety concerns.

Roche introduces navify® Algorithm Suite, a digital library of medical algorithms that enhances clinical decision-making to optimise patient care

At the global HIMSS1 Conference, Roche showcases navify Algorithm Suite, a single platform offering clinicians access to medical algorithms generating insights to help improve care decisions.

PathO3Gen Solutions UVZone® Proven 99.9993% Effective Against Candida Auris: Shoes and Floors in Healthcare Facilities Should Be Addressed as Outbreak Continues

PathO3Gen Solutions’ multi-patented UVZone Shoe Sanitizing Stations, when placed in high-traffic and high-risk areas, enhance healthcare facility infection control measures, and may improve overall hospital biosafety.

Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.

Under the terms of Pharming's 2019 exclusive license agreement with Novartis for leniolisib, the corresponding first commercial sale of Joenja® triggers a $10 million milestone payment by Pharming to Novartis.

April 1, 2021

IAI (Intelligent Actuator Incorporated) would like to introduce their ELECYLINDER® electric actuator series.

The main features are easy operation, AVD (acceleration/speed/deceleration) that can be adjusted individually, and high performance. Due to its stable quality, it is ideal for the manufacturing industry of medical products where product accuracy is required.

Here is an example of how the smooth operation of ELECYLINDER® improved a packaging application. Previously, an air cylinder was used to transfer accepted products. To achieve a shorter cycle time, the air cylinder was operated at a high speed but gave a big shock at the time of the stoppage. As a result, some temporary stops took place in the post-process due to the dispersion of transferred positions of accepted products. Since the ELECYLINDER can adjust acceleration/deceleration, there is no shock even at a high-speed operation. As a result, the dispersion of the transferred positions was eliminated, reducing temporary stops and shortening the cycle time.

ELECYLINDER® makes it easy to adjust and control AVD (A: Acceleration, V: Speed, D: Deceleration), allowing packages to move smoothly between conveyors positioned at right angles without affecting internal products. In addition, ELECYLINDER® has a wide range of products available for many types of applications.

“IAI is proud to be at the forefront of technology that supports the medical community in the fight against disease and future health crises,” said Kaz Haruna, National Sales Manager at IAI America.

IAI is actively assisting the medical community by providing Cartesian and SCARA robots for infectious disease testing, molecular diagnostics, tissue and blood sampling, genomic research, cancer research, pharmaceuticals, and medical device production. It is IAI’s hope that our ELECYLINDER® Series will help the medical/pharmaceutical industries move ahead with advanced innovation.

Latest Posts

Learn More

spot_img

Subscribe

spot_img

Our Sister Publication

Medical Device News Magazine